Westside Investment Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Westside Investment Management's EDIT Position: Q4 2025 in Review
Westside Investment Management sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 200 shares — an estimated $695 sold.
Westside Investment Management first reported a position in EDIT in Q1 2020 and held it in 23 quarters. The position peaked at $106K in Q1 2020. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.
- Westside Investment Management reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
- Westside Investment Management sold 200 Editas Medicine shares in Q4 2025, an estimated $695.
- Westside Investment Management first reported a position in Editas Medicine in Q1 2020 and held it in 23 quarters.
- Westside Investment Management's Editas Medicine position peaked at $106K in Q1 2020.
- 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.
Based on Westside Investment Management's 13F filing for Q4 2025, filed 23 Jan 2026.